TY  - GEN
AU  - Erčulj,Nina
AU  - Kovač,Viljem
AU  - Hmeljak,Julija
AU  - Franko,Alenka
AU  - Dodič-Fikfak,Metoda
AU  - Dolžan,Vita
TI  - The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma
SN  - 1744-6880
PY  - 2012///0618
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Pharmacological
KW  - Cytidine Deaminase
KW  - genetics
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Deoxycytidine Kinase
KW  - Disease-Free Survival
KW  - Female
KW  - Genetic Association Studies
KW  - Genotype
KW  - Haplotypes
KW  - Humans
KW  - Male
KW  - Mesothelioma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Polymorphism, Single Nucleotide
KW  - Promoter Regions, Genetic
KW  - Retrospective Studies
KW  - Ribonucleoside Diphosphate Reductase
KW  - Treatment Outcome
KW  - Tumor Suppressor Proteins
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/FPC.0b013e32834e3572
ER  -